Innovent and AnHeart Announce Interim Data from Phase 2 Trial of Taletrectinib in ROS1-Positive NSCLC at the CSCO 2021 Annual Meeting September 26, 2021
Behavioral Health Leader Christina Mainelli Joins Quartet Health to Accelerate Strategic Growth September 23, 2021
Verve Therapeutics Announces Development of Proprietary GalNAc-LNP Delivery Technology Enabling Efficient In Vivo Liver Delivery of Base Editors September 23, 2021
Innovent Announces First Patient Dosed in a Phase 2 Clinical Trial of IBI112 (IL-23 Monoclonal Antibody) in Patients with Moderate-to-severe Plaque Psoriasis September 23, 2021
Owkin’s deep learning AI predicts chances of metastatic breast cancer relapse within next 5 years September 22, 2021
Centivo raises $51 million as more employers seek affordable, quality healthcare for their employees September 22, 2021
NOCD Raises $33 Million to Address Global OCD Crisis; Series B Financing to Support People Struggling with OCD, Fuel Growth September 21, 2021
WellAir announces agreement with Vizient, Inc. to help expand air and surface disinfection technologies to healthcare facilities September 21, 2021